GEFCC is excited to announce the launch of a brand-new program, our Substance Use Disorder (SUD) and Medication Assisted Treatment (MAT) Program!
Starting April 1st, 2019, patients of GEFCC will be able to receive SUD/MAT services at Center for Family Health in Sycamore. As our program grows, we will be expanding services to other Health Centers as well.
Medication Assisted Treatment (MAT) is the use of medications, in combination with counseling and behavioral therapies, to provide a “whole-patient” approach to the treatment of substance use disorders. Research shows that a combination of medication and therapy can successfully treat these disorders, and for some people struggling with addiction, MAT can help sustain recovery.
This program is available for any adult (18 years and older) who struggles with an Opioid Use Disorder. Patients can be referred to the MAT Program by their insurance, court system, substance abuse and mental health treatment providers, primary care providers, and self-referred. Through the program, participants will receive Buprenorphine in combination with outpatient behavioral health counseling and group therapy.
According to the National Institute on Drug Abuse, over 2.5 million Americans suffer from opioid use disorder, which contributes to an average of 130 overdose deaths every day in the U.S. Use of opioids, including heroin and prescription pain relievers, can lead to many other health concerns including, neonatal abstinence syndrome as well as the spread of infectious diseases like HIV and Hepatitis. The misuse of, and addiction to, opioids is a serious national crisis that affects public health as well as social and economic welfare.
GEFCC is helping address the national opioid epidemic by offering innovative medications and therapies to treat opioid use disorders. GEFCC’s SUD/MAT Program will improved overdose prevention and reversal interventions to save lives and support recovery. Research shows MAT increases social functioning and retention in treatment. Patients treated with medication were more likely to remain in therapy compared to patients receiving treatment that did not include medication.